Fibrin-specific plasminogen activator TNKase (tenecteplase) is the first stroke medicine approved by the FDA in nearly 30 years, joining Roche/Genentech's Activase (alteplase), which is the only ...

According to Genentech, the partnership will help to transform its GenAI models and algorithms into a “next-generation AI platform” operating at the interface between biology and computation.

Instill 1 mL of alteplase 0.5 mg/mL into the catheter. If the catheter has a capacity of >1 mL, follow the alteplase with 0.9% sodium chloride injection. Allow the solution to dwell for 60 minutes.